AMY PETERSON: Open Payments
NPI 1700390754 · LAKE VIEW, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,833 in 137 payments from 25 companies in 2025. Trend: 2023 $2,662 · 2024 $2,859 · 2025 $2,833
Food & beverage: $2,833
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 20 | $392 |
| AstraZeneca Pharmaceuticals LP | 12 | $314 |
| Novo Nordisk Inc | 14 | $272 |
| Lilly USA, LLC | 14 | $271 |
| GlaxoSmithKline, LLC. | 10 | $196 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $171 |
| ABBVIE INC. | 9 | $142 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $119 |
| Axsome Therapeutics, Inc. | 6 | $117 |
| Exact Sciences Corporation | 5 | $111 |
Products named: AIRSUPRA, CAPLYTA, JARDIANCE, TRELEGY ELLIPTA, MOUNJARO, XIFAXAN, NURTEC ODT, ELIQUIS.
Industry payments across NY — which companies pay providers there.
